Работайте офлайн с приложением Player FM !
Edgewood Arsenal Human Experiments
Manage episode 442312978 series 2574950
From 1948 to 1975, the U.S. Army Chemical Corps conducted classified experiments on over 8,000 individuals at the Edgewood Arsenal. These experiments were conducted primarily to learn how various agents would affect humans. Also, multiple drugs were developed at this facility, including one that made individuals “trip” for 5-10 days straight and have vivid hallucinations for 3 continuous days. This Episode was Originally released as a Premium Episode on August 15th, 2024.
To watch the podcast on YouTube: https://bit.ly/TheoriesOfTheThirdKindYT
Don’t forget to follow the podcast for free wherever you're listening or by using this link: https://bit.ly/TheoriesoftheThirdKindPod
https://theoriesofthethirdkind.com/
Learn more about your ad choices. Visit podcastchoices.com/adchoices
215 эпизодов
Manage episode 442312978 series 2574950
From 1948 to 1975, the U.S. Army Chemical Corps conducted classified experiments on over 8,000 individuals at the Edgewood Arsenal. These experiments were conducted primarily to learn how various agents would affect humans. Also, multiple drugs were developed at this facility, including one that made individuals “trip” for 5-10 days straight and have vivid hallucinations for 3 continuous days. This Episode was Originally released as a Premium Episode on August 15th, 2024.
To watch the podcast on YouTube: https://bit.ly/TheoriesOfTheThirdKindYT
Don’t forget to follow the podcast for free wherever you're listening or by using this link: https://bit.ly/TheoriesoftheThirdKindPod
https://theoriesofthethirdkind.com/
Learn more about your ad choices. Visit podcastchoices.com/adchoices
215 эпизодов
Все серии
×Добро пожаловать в Player FM!
Player FM сканирует Интернет в поисках высококачественных подкастов, чтобы вы могли наслаждаться ими прямо сейчас. Это лучшее приложение для подкастов, которое работает на Android, iPhone и веб-странице. Зарегистрируйтесь, чтобы синхронизировать подписки на разных устройствах.